Compare · CHE vs DCGO
CHE vs DCGO
Side-by-side comparison of Chemed Corp (CHE) and DocGo Inc. (DCGO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and DCGO operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.74B, about 241.5x DCGO ($27.9M).
- CHE has been more active in the news (4 items in the past 4 weeks vs 1 for DCGO).
- DCGO has more recent analyst coverage (10 ratings vs 7 for CHE).
- Company
- Chemed Corp
- DocGo Inc.
- Price
- -
- -
- Market cap
- $6.74B
- $27.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 4
- 1
- Recent ratings
- 7
- 10
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
DocGo Inc.
DocGo, Inc. provides mobile health services and integrated medical mobility solutions in 26 states in the United States and the United Kingdom. The company's AI-powered transportation and concierge medical services enable its clinical professionals to facilitate patient-centered care, helping improve patient outcomes while reducing the total cost of care for its customers. It also provides medical transport services. As of October 1, 2021, the company had 3,500 medical providers. It serves facilities, hospital networks, and health insurance providers. The company was founded in 2015 and is headquartered in New York, New York.
Latest CHE
- Executive vice president Lee Spencer S exercised 12,099 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 11,160 units of Capital Stock, increasing direct ownership by 7% to 14,851 units (SEC Form 4)
- Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
- President and CEO Mcnamara Kevin J sold $1,026,900 worth of Capital Stock (2,000 units at $513.45), decreasing direct ownership by 3% to 66,418 units (SEC Form 4)
- Vice president Hutton Thomas C exercised 4,629 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 4,270 units of Capital Stock, increasing direct ownership by 1% to 32,840 units (SEC Form 4)
- UBS initiated coverage on Chemed with a new price target
- President and CEO Mcnamara Kevin J sold $1,002,800 worth of Capital Stock (2,000 units at $501.40), decreasing direct ownership by 3% to 68,418 units (SEC Form 4)
- Roto-Rooter Buys Largest Franchisee Territory
- Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
Latest DCGO
- DocGo Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition
- DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 10-Q filed by DocGo Inc.
- DocGo Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits
- DocGo Announces Second Quarter 2026 Results
- DocGo to Announce Second Quarter 2026 Results on Monday, August 17, 2026
- SEC Form NT 10-Q filed by DocGo Inc.
- DocGo Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- DocGo Inc. filed SEC Form 8-K: Regulation FD Disclosure